[Red blood cell immunization in haemoglobinopathie: about 84 cases]. (Q50501314)

14 March 2018

title

[Red blood cell immunization in haemoglobinopathie: about 84 cases]. (English)

1 reference

14 March 2018

0 references

I Ben Amor

1

1 reference

14 March 2018

N Louati

2

1 reference

14 March 2018

H Khemekhem

3

1 reference

14 March 2018

A Dhieb

4

1 reference

14 March 2018

H Rekik

5

1 reference

14 March 2018

M Mdhaffar

6

1 reference

14 March 2018

J Gargouri

7

1 reference

14 March 2018

publication date

25 October 2012

1 reference

14 March 2018

Transfusion Clinique et Biologique

published in

1 reference

14 March 2018

volume

19

1 reference

14 March 2018

issue

6

1 reference

14 March 2018

page(s)

345-352

1 reference

14 March 2018

Post-transfusion alloimmunization in patients with sickle cell disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Red cell alloantibodies in patients with thalassemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Alloimmunization to red blood cell antigens by transfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Severe reactions associated with transfusion of patients with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Alloimmunization to red cell antigens in thalassemia: comparative study of usual versus better-match transfusion programmes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Problems of chronic transfusion in sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Alloimmunization in two multitransfused patient populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Should chronic transfusions be matched for antigens other than ABO and Rho(D)?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Immune response to chronic red blood cell transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Sickle cell disease in North London

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Red cell alloimmunization in sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

RBC alloimmunization and autoimmunization among transfusion‐dependent Arab thalassemia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Red blood cell alloimmunization in sickle cell disease patients in Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

[Transfusion and alloimmunization in sickle cell anemia patients]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

[Severe hemolysis related to an association of erythrocyte allo- and autoantibodies in a thalassemia patients]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Transfusion medicine in a developing country - alloantibodies to red blood cells in multi-transfused patients in Saudi Arabia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

[Study of 206 transfused sickle cell disease patients: immunization, transfusion safety and red blood cell supply].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Association of HLA and autoantibody in transfused sickle cell disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Changes in peripheral blood CD5 (Bla) B-cell populations and autoantibodies following blood transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Increased IgA natural autoantibody activity in sera of patients with homozygous beta-thalassaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Combined sickle cell disease and autoimmune hemolytic anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Red blood cell transfusion in warm-type autoimmune haemolytic anaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Current issues with blood transfusions in sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Alloimmunization in patients with warm autoantibodies. A retrospective study employing three donor alloabsorptions to aid in antibody detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

Development of direct antiglobulin reaction accompanying alloimmunization in a patient with Rhd (D, category III) phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.06.006

10.1016/J.TRACLI.2012.06.006

7 January 2021

Identifiers

DOI

1 reference

14 March 2018

1 reference

14 March 2018